Cargando…

Cannabinoids in Late Life Parkinson’s Disease and Dementia: Biological Pathways and Clinical Challenges

The use of cannabinoids as therapeutic drugs has increased among aging populations recently. Age-related changes in the endogenous cannabinoid system could influence the effects of therapies that target the cannabinoid system. At the preclinical level, cannabidiol (CBD) induces anti-amyloidogenic, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Costa, Alana C., Joaquim, Helena P. G., Pedrazzi, João F. C., Pain, Andreia de O., Duque, Gustavo, Aprahamian, Ivan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775654/ https://www.ncbi.nlm.nih.gov/pubmed/36552056 http://dx.doi.org/10.3390/brainsci12121596

Ejemplares similares

Challenges and Perspectives in the Management of Late-Stage Parkinson’s Disease
por: Fabbri, Margherita, et al.
Publicado: (2020)

Cannabinoids in Parkinson's Disease
por: Stampanoni Bassi, Mario, et al.
Publicado: (2017)

Clinical Diagnostic Criteria Have a High Impact on the Frequency of Dementia in Late-Stage Parkinson's Disease
por: Severiano e Sousa, Catarina, et al.
Publicado: (2021)

Speech and Voice Response to a Levodopa Challenge in Late-Stage Parkinson’s Disease
por: Fabbri, Margherita, et al.
Publicado: (2017)

Overview of Synthetic Cannabinoids ADB-FUBINACA and AMB-FUBINACA: Clinical, Analytical, and Forensic Implications
por: Lobato-Freitas, Carolina, et al.
Publicado: (2021)

Cannabinoids and Dementia: A Review of Clinical and Preclinical Data
por: Walther, Sebastian, et al.
Publicado: (2010)

Saturated Cannabinoids: Update on Synthesis Strategies and Biological Studies of These Emerging Cannabinoid Analogs
por: Docampo-Palacios, Maite L., et al.
Publicado: (2023)

Shaping the next steps of research on frailty: challenges and opportunities
por: Aprahamian, Ivan, et al.
Publicado: (2021)

Medical cannabinoids for treatment of neuropsychiatric symptoms in dementia: a systematic review
por: Stella, Florindo, et al.
Publicado: (2021)

Dementia and Parkinson's Disease: Similar and Divergent Challenges in Providing Palliative Care
por: van der Steen, Jenny T., et al.
Publicado: (2019)

Roles of the Cannabinoid System in the Basal Ganglia in Parkinson’s Disease
por: Wang, Mengya, et al.
Publicado: (2022)

The Role of Cannabinoid Type 2 Receptors in Parkinson’s Disease
por: Basile, Maria Sofia, et al.
Publicado: (2022)

Analysis of Cannabinoids in Biological Specimens: An Update
por: Antunes, Mónica, et al.
Publicado: (2023)

Personalized Care in Late-Stage Parkinson’s Disease: Challenges and Opportunities
por: Fabbri, Margherita, et al.
Publicado: (2022)

The Clock Drawing Test: A review of its accuracy in screening for dementia
por: Aprahamian, Ivan, et al.
Publicado: (2009)

Commentary: Roles of the Cannabinoid System in the Basal Ganglia in Parkinson's Disease
por: Oikonomou, Panteleimon, et al.
Publicado: (2022)

Dementia in Parkinsonism
Publicado: (2011)

High frequency of psychosis in late-stage Parkinsońs disease
por: Chendo, Inês, et al.
Publicado: (2021)

Profile of cognitive impairment in late‐stage Parkinson's disease
por: Severiano e Sousa, Catarina, et al.
Publicado: (2022)

Promising cannabinoid-based therapies for Parkinson’s disease: motor symptoms to neuroprotection
por: More, Sandeep Vasant, et al.
Publicado: (2015)

Microglial Phenotypes and Their Relationship to the Cannabinoid System: Therapeutic Implications for Parkinson’s Disease
por: Kelly, Rachel, et al.
Publicado: (2020)

Dementia and functional decline in patients with Parkinson’s disease
por: Stella, Florindo, et al.
Publicado: (2008)

The current state and future perspectives of cannabinoids in cancer biology
por: Śledziński, Paweł, et al.
Publicado: (2018)

The current state and future perspectives of cannabinoids in cancer biology
Publicado: (2018)

The Synthetic Cannabinoids THJ-2201 and 5F-PB22 Enhance In Vitro CB(1) Receptor-Mediated Neuronal Differentiation at Biologically Relevant Concentrations
por: Alexandre, João, et al.
Publicado: (2020)

Safety and effectiveness of cannabinoids for the treatment of neuropsychiatric symptoms in dementia: a systematic review
por: Hillen, Jodie Belinda, et al.
Publicado: (2019)

Recent data on cannabinoids and their pharmacological implications in neuropathic pain
por: Oana, Andreia Coman, et al.
Publicado: (2008)

Performance of the Pentagon Drawing test for the screening of older adults with Alzheimer's dementia
por: Martinelli, José Eduardo, et al.
Publicado: (2018)

The Frail Depressed Patient: A Narrative Review on Treatment Challenges
por: Aprahamian, Ivan, et al.
Publicado: (2022)

Cerebrospinal fluid biomarkers in Alzheimer's disease: Diagnostic accuracy and prediction of dementia
por: Forlenza, Orestes V., et al.
Publicado: (2015)

Challenges and Opportunities in Preclinical Research of Synthetic Cannabinoids for Pain Therapy
por: Tamba, Bogdan Ionel, et al.
Publicado: (2020)

An Individuality of Response to Cannabinoids: Challenges in Safety and Efficacy of Cannabis Products
por: Kitdumrongthum, Sarunya, et al.
Publicado: (2023)

Cannabinol: History, Syntheses, and Biological Profile of the Greatest “Minor” Cannabinoid
por: Maioli, Chiara, et al.
Publicado: (2022)

Short- and Long-Term Cognitive Effects of Chronic Cannabinoids Administration in Late-Adolescence Rats
por: Abush, Hila, et al.
Publicado: (2012)

Cognitive Impairment and Dementia in Parkinson’s Disease: Clinical Features, Diagnosis, and Management
por: Meireles, Joana, et al.
Publicado: (2012)

Rivastigmine for the treatment of dementia associated with Parkinson’s disease
por: Reingold, Jennifer L, et al.
Publicado: (2007)

Treatment in late Parkinson's disease
Publicado: (2011)

Cannabinoids for clinicians: the rise and fall of the cannabinoid antagonists
por: Butler, Helen, et al.
Publicado: (2009)

Cannabinoids and Cannabinoid Receptors: The Story so Far
por: Shahbazi, Fred, et al.
Publicado: (2020)

Cannabinoid Biosynthesis Using Noncanonical Cannabinoid Synthases
por: Go, Maybelle Kho, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ir556hdiaguikvum46so4ds1l6